Decoding the Adaptive Immune System at Scale

We empower people and researchers to decode the adaptive immune repertoire, making immune data accessible, understandable, and actionable

Scroll to explore
Immune system visualization

A Molecular Language Waiting to Be Decoded

The adaptive immune system records a lifetime of exposures: infections and vaccines. Your future is determined by your past. Cracking that code would let us detect disease years earlier and personalize treatments to an individual's immune history.

Bridging Computation and Immunity

We decode the adaptive immune system signals and make them accessible to researchers and clinicians.

Cognate integrates computational immunology, high-throughput sequencing, and machine learning to decode T-cell repertoires, revealing immune signals to guide diagnostics, therapies, and personalized medicine.

TCR Sequencing
Causal Inference
Population-level Insights
Intuitive Platform

Three Pillars of Democratizing Immune Intelligence

High-Throughput TCR Sequencing

Comprehensive profiling of T cell populations across cohorts and timepoints, capturing immune dynamics.

Sequencing
immunology

Foundational Model & Causal Inference

Machine learning models trained on vast datasets of immune responses to understand the underlying mechanisms of immunity and causal inference to predict the effect of interventions.

AI models
Causality

Intuitive Analysis Platform

End-to-end analysis pipelines built for population-level insights and real-world decision-making.

Software
Bio-informatics

Led by experts in AI & immunology

Philippe Brouillard

Philippe Brouillard

Chief Executive Officer

AI researcher and causal inference expert. Building the bridge between machine learning theory and immune system understanding.

Assya Trofimov

Assya Trofimov

Chief Technology Officer

Computational immunologist and T-cell expert. Pioneering new methods for understanding adaptive immunity.

Ready to decode your adaptive immune system?

Interested in learning more about our technology? We'd love to hear from you.